FI114637B - Menetelmä terapeuttisesti käytettävien substituoitujen kinuklidiinien valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käytettävien substituoitujen kinuklidiinien valmistamiseksi Download PDF

Info

Publication number
FI114637B
FI114637B FI934752A FI934752A FI114637B FI 114637 B FI114637 B FI 114637B FI 934752 A FI934752 A FI 934752A FI 934752 A FI934752 A FI 934752A FI 114637 B FI114637 B FI 114637B
Authority
FI
Finland
Prior art keywords
carbon atoms
alkyl
compounds
substituted
formula
Prior art date
Application number
FI934752A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI934752A0 (fi
FI934752A (fi
Inventor
Kunio Satake
Hiroaki Wakabayashi
Masami Nakane
Fumitaka Ito
Toshihide Kokura
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI934752A0 publication Critical patent/FI934752A0/fi
Publication of FI934752A publication Critical patent/FI934752A/fi
Application granted granted Critical
Publication of FI114637B publication Critical patent/FI114637B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
FI934752A 1992-10-28 1993-10-27 Menetelmä terapeuttisesti käytettävien substituoitujen kinuklidiinien valmistamiseksi FI114637B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4290569A JP2656700B2 (ja) 1992-10-28 1992-10-28 置換キヌクリジン誘導体
JP29056992 1992-10-28

Publications (3)

Publication Number Publication Date
FI934752A0 FI934752A0 (fi) 1993-10-27
FI934752A FI934752A (fi) 1994-04-29
FI114637B true FI114637B (fi) 2004-11-30

Family

ID=17757724

Family Applications (1)

Application Number Title Priority Date Filing Date
FI934752A FI114637B (fi) 1992-10-28 1993-10-27 Menetelmä terapeuttisesti käytettävien substituoitujen kinuklidiinien valmistamiseksi

Country Status (14)

Country Link
EP (1) EP0665843B1 (fr)
JP (1) JP2656700B2 (fr)
AT (1) ATE247113T1 (fr)
AU (1) AU5141293A (fr)
CA (1) CA2146007C (fr)
DE (1) DE69333143T2 (fr)
DK (1) DK0665843T3 (fr)
ES (1) ES2202313T3 (fr)
FI (1) FI114637B (fr)
HU (1) HUT65831A (fr)
IL (1) IL107346A0 (fr)
MX (1) MX9306704A (fr)
PT (1) PT665843E (fr)
WO (1) WO1994010170A1 (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL109646A0 (en) * 1993-05-19 1994-08-26 Pfizer Heteroatom substituted alkyl benzylamino-quinuclidines
ES2121213T3 (es) * 1993-07-15 1998-11-16 Pfizer Benciloxiquinuclidinas como antagonistas de la sustancia p.
PT719253E (pt) * 1993-09-17 2004-07-30 Pfizer Piperidinas 3-amino-5-carboxi-substituidas e pirrolidinas 3-amino-4-carboxi-substituidas como antagonistas de taquicinina
US6083943A (en) * 1993-09-17 2000-07-04 Pfizer Inc Substituted azaheterocyclecarboxylic acid
CA2205016A1 (fr) * 1994-11-10 1996-05-23 Hans-Jurgen Ernst Hess Antagonistes du recepteur nk-1 destines au traitement de troubles oculaires
MX9706944A (es) * 1996-09-12 1998-08-30 Pfizer Quinuclidinas sustituidas con tetrazolilo como antagonistas de la sustancia p.
US6861526B2 (en) 2002-10-16 2005-03-01 Pfizer Inc. Process for the preparation of (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine
ZA200701232B (en) 2004-07-15 2008-08-27 Amr Technology Inc Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
ES2382814T3 (es) 2005-05-17 2012-06-13 Merck Sharp & Dohme Ltd. Ácido cis-4-[(4-clorofenil)sulfonil]-4-(2,5-difluorofenil)ciclohexanopropanoico para el tratamiento del cáncer
EP1904069B1 (fr) 2005-07-15 2018-06-13 Albany Molecular Research, Inc. Tetrahydrobenzazepines substituees par aryle et heteroaryle, et leur utilisation pour bloquer la reabsorption de la noradrenaline, de la dopamine, et de la serotonine
US8293900B2 (en) 2005-09-29 2012-10-23 Merck Sharp & Dohme Corp Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
GB0603041D0 (en) 2006-02-15 2006-03-29 Angeletti P Ist Richerche Bio Therapeutic compounds
CA2664113C (fr) 2006-09-22 2013-05-28 Merck & Co., Inc. Utilisation de la platencine et de la platensimycine en tant qu'inhibiteurs de la synthese des acides gras pour traiter l'obesite, lediabete et le cancer
US20110218176A1 (en) 2006-11-01 2011-09-08 Barbara Brooke Jennings-Spring Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
BRPI0806245B1 (pt) 2007-01-10 2022-01-25 Msd Italia S.R.L. Compostos de fórmula i e seus usos
CA2682727C (fr) 2007-04-02 2016-03-22 Banyu Pharmaceutical Co., Ltd. Derive d'indoledione
EP2170076B1 (fr) 2007-06-27 2016-05-18 Merck Sharp & Dohme Corp. Dérivés de 4-carboxybenzylamino utilisés en tant qu'inhibiteurs de l'histone désacétylase
US8598184B2 (en) 2008-03-03 2013-12-03 Tiger Pharmatech Protein kinase inhibitors
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
US8691825B2 (en) 2009-04-01 2014-04-08 Merck Sharp & Dohme Corp. Inhibitors of AKT activity
KR20120034644A (ko) 2009-05-12 2012-04-12 알바니 몰레큘라 리써치, 인크. 아릴, 헤테로아릴, 및 헤테로사이클 치환된 테트라하이드로이소퀴놀린 및 이의 용도
CN102638982B (zh) 2009-05-12 2015-07-08 百时美施贵宝公司 (S)-7-([1,2,4]三唑并[1,5-a]吡啶-6-基)-4-(3,4-二氯苯基)-1,2,3,4-四氢异喹啉的晶型及其用途
CA2760837C (fr) 2009-05-12 2018-04-03 Albany Molecular Research, Inc. 7-([1,2,4]triazolo[1,5-.alpha.]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline et son utilisation
WO2011046771A1 (fr) 2009-10-14 2011-04-21 Schering Corporation Pipéridines substituées qui accroissent l'activité de p53, et utilisations de ces composés
WO2011163330A1 (fr) 2010-06-24 2011-12-29 Merck Sharp & Dohme Corp. Nouveaux composés hétérocycliques utilisés comme inhibiteurs de erk
CA2805265A1 (fr) 2010-08-02 2012-02-09 Merck Sharp & Dohme Corp. Inhibition a mediation par interference arn de catenine (proteine associee a cadherine), expression du gene beta 1 (ctnnb1) a l'aide de petit acide nucleique interferent (sian)
WO2012024170A2 (fr) 2010-08-17 2012-02-23 Merck Sharp & Dohme Corp. Inhibition médiée par des arn interférents de l'expression génique du virus de l'hépatite b (vhb) à l'aide de petits acides nucléiques interférents (pani)
US8883801B2 (en) 2010-08-23 2014-11-11 Merck Sharp & Dohme Corp. Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors
US8946216B2 (en) 2010-09-01 2015-02-03 Merck Sharp & Dohme Corp. Indazole derivatives useful as ERK inhibitors
EP2615916B1 (fr) 2010-09-16 2017-01-04 Merck Sharp & Dohme Corp. Dérivés condensés de pyrazole utilisés comme nouveaux inhibiteurs erk
WO2012058210A1 (fr) 2010-10-29 2012-05-03 Merck Sharp & Dohme Corp. INHIBITION FACILITÉE PAR L'INTERFÉRENCE D'ARN DE L'EXPRESSION D'UN GÈNE AU MOYEN D'ACIDES NUCLÉIQUES INTERFÉRENTS COURTS (siNA)
WO2012087772A1 (fr) 2010-12-21 2012-06-28 Schering Corporation Dérivés d'indazole utiles en tant qu'inhibiteurs de erk
JP2014514321A (ja) 2011-04-21 2014-06-19 メルク・シャープ・アンド・ドーム・コーポレーション インスリン様増殖因子１受容体阻害剤
US9023865B2 (en) 2011-10-27 2015-05-05 Merck Sharp & Dohme Corp. Compounds that are ERK inhibitors
US20150299696A1 (en) 2012-05-02 2015-10-22 Sirna Therapeutics, Inc. SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS
WO2014052563A2 (fr) 2012-09-28 2014-04-03 Merck Sharp & Dohme Corp. Nouveaux composés inhibiteurs de erk
MX363243B (es) 2012-11-28 2019-03-14 Merck Sharp & Dohme Composiciones para tratar cáncer y usos de dichas composiciones.
RU2690663C2 (ru) 2012-12-20 2019-06-05 Мерк Шарп И Доум Корп. Замещенные имидазопиридины в качестве ингибиторов hdm2
US9540377B2 (en) 2013-01-30 2017-01-10 Merck Sharp & Dohme Corp. 2,6,7,8 substituted purines as HDM2 inhibitors
US20160194368A1 (en) 2013-09-03 2016-07-07 Moderna Therapeutics, Inc. Circular polynucleotides
US10947234B2 (en) 2017-11-08 2021-03-16 Merck Sharp & Dohme Corp. PRMT5 inhibitors
WO2020033284A1 (fr) 2018-08-07 2020-02-13 Merck Sharp & Dohme Corp. Inhibiteurs de prmt5
EP3833668A4 (fr) 2018-08-07 2022-05-11 Merck Sharp & Dohme Corp. Inhibiteurs de prmt5

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX18467A (es) * 1988-11-23 1993-07-01 Pfizer Agentes terapeuticos de quinuclidinas
HUT65771A (en) * 1991-05-22 1994-07-28 Pfizer Process for producing substituted 3-amino-quinuclidine derivatives and pharmaceutical compositions containing them
JP2719063B2 (ja) * 1991-05-22 1998-02-25 ファイザー製薬株式会社 置換３−アミノキヌクリジンｐ物質拮抗剤

Also Published As

Publication number Publication date
CA2146007A1 (fr) 1994-05-11
HUT65831A (en) 1994-07-28
AU5141293A (en) 1994-05-24
JPH06135964A (ja) 1994-05-17
ES2202313T3 (es) 2004-04-01
WO1994010170A1 (fr) 1994-05-11
HU9303051D0 (en) 1994-01-28
DK0665843T3 (da) 2003-12-01
ATE247113T1 (de) 2003-08-15
FI934752A0 (fi) 1993-10-27
CA2146007C (fr) 1999-02-23
DE69333143T2 (de) 2004-02-26
JP2656700B2 (ja) 1997-09-24
DE69333143D1 (de) 2003-09-18
MX9306704A (es) 1995-01-31
IL107346A0 (en) 1994-01-25
EP0665843B1 (fr) 2003-08-13
FI934752A (fi) 1994-04-29
EP0665843A1 (fr) 1995-08-09
PT665843E (pt) 2003-12-31

Similar Documents

Publication Publication Date Title
FI114637B (fi) Menetelmä terapeuttisesti käytettävien substituoitujen kinuklidiinien valmistamiseksi
AP120A (en) Quinuclidine therapeutic agents
EP0632809B1 (fr) Derives de quinuclidine utiles comme antagonistes de la substance p
US5422354A (en) Quinuclidine derivatives
FI114636B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten bentsyyliaminokinuklidiinijohdannaisten valmistamiseksi
PL170513B1 (en) Method of obtaining novel derivatives of 3-amino quinuclidine
PL186773B1 (pl) Nowe pochodne benzyloaminopiperydyny i środek farmaceutyczny
AU2681392A (en) Acyclic ethylenediamine derivatives as substance p receptor antagonists
US5604241A (en) Substituted benzylaminoquinuclidines as substance P antagonists
US5569662A (en) Quinuclidine derivatives as substance P antagonists
US5789423A (en) 3- 5-substituted benzyl)amino!-2-phenylpiperidines as substance P antagonists
CA2215020C (fr) Quinuclidines substituees par un tetrazolyle comme antagonistes de la substance p
US5837711A (en) Substituted quinuclidines as substance P antagonists
US4800207A (en) Hexahydropyrrolizine compounds useful as analgesics
JP3172461B2 (ja) サブスタンスｐアンタゴニストとしての３−［（５−置換ベンジル）アミノ］−２−フェニルピペリジン

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 114637

Country of ref document: FI